ROBERT CALIFF

The head of the Food and Drug Administration says a comprehensive review of the opioid painkillers that triggered the nation's ongoing overdose epidemic is in the works.

The latest data shows nearly one-third of powdered formula products are still out of stock nationwide.

The FDA's tobacco center, which regulates traditional cigarettes and vaping products, is facing challenges navigating policy and enforcement issues.

The head of the Food and Drug Administration is asking for a review of the agency’s food and tobacco programs.

The U.S. is getting another COVID-19 vaccine choice.

The Biden administration says it has secured 3.2 million doses of the vaccine.

Abbot Nutrition says baby formula production has resumed at the Michigan plant whose February shutdown over contamination contributed to a national shortage.

Before shots can be administered to kids as young as 6 months old, the CDC's vaccine advisers are scheduled to vote on updated recommendations this Saturday.

Production for Abbott's EleCare specialty formula has been suspended, but there is enough supply to meet demand until production is restarted, the company said​.

Severe weather has forced Abbott Nutrition to pause production at a Michigan baby formula factory that had just restarted.

Less than two weeks after restarting formula production at its Michigan facility, Abbott has again had to halt manufacturing there amid flooding.

U.S. regulators have historically inspected baby formula plants at least once a year, but they did not inspect any of the three biggest manufacturers in 2020.

Abbott says it's restarted production at the Michigan factory that's tied to the ongoing baby formula shortage.

FDA Commissioner Dr. Robert Califf said it will take about two months for shelves to be full with formula again.

Commissioner Robert Califf admitted the agency's reaction was "too slow," while a formula maker exec apologized to parents.

Sluggish response and questionable decisions by the Food and Drug Administration exacerbated the nation's infant formula shortage, officials say.

Abbott Nutrition and U.K.-based Kendal Nutricare plan to ship more than 2 million cans of formula.

Abbott Nutrition and U.K.-based Kendal Nutricare plan to ship more than 2 million cans of formula.

The FDA and President Joe Biden face mounting political pressure to explain why they didn't intervene earlier to try and address the supply problems.

The FDA and President Joe Biden face mounting political pressure to explain why they didn't intervene earlier to try and address the supply problems.

Members of Congress began a House subcommittee hearing Tuesday by accusing north suburban-based Abbott Laboratories of negligence

FDA Commissioner Robert Califf will answer questions from House lawmakers about what's caused the formula shortage.

The House Oversight and Investigations subcommittee hearing will begin at 11 a.m.

The head of the Food and Drug Administration faced a congressional grilling over a months-long delay in inspecting the plant at the center of a nationwide baby formula shortage.

WASHINGTON (AP) — The head of the Food and Drug Administration told lawmakers Thursday that a shuttered baby formula factory could be up and running as soon as next week, though he sidestepped questio[San Marcos, TX] [Hays County news] News San Marcos News, San Marcos Record [Texas State]

But Abbott has said that, after production resumes, it could take about two months before new formula begins arriving in stores. The company's factory has been closed due to contamination problems.

The Abbott Nutrition formula plant in Michigan will re-open, pending safety upgrades and certifications.

The FDA closed the plant in February — after four infants who drank formula produced there contracted bacterial infections, two of whom died.

Republicans argued that the plan didn't force federal agencies to look for formula that could be redirected to U.S. homes immediately.

The Food and Drug Administration's commissioner says a shuttered baby formula factory could be up and running by next week.

Many questions remain about the shuttered Abbott baby formula plant at the center of a nationwide shortage.

The Food and Drug Administration on Tuesday authorized a Pfizer booster dose for children ages 5 through 11 years old at least five months after they complete their two-dose primary series. Dr. Peter Marks, head of the FDA division responsible for vaccines, said data increasingly shows that the protection provided by two shots wanes off over time. The FDA determined that a third shot can help boost protection for children in this age group and the benefits outweigh the risks, Marks said. The FDA did not convene its committee of independent experts to discuss the data before authorizing the booster dose. New hospital admissions of people with Covid have also increased 8% over the past week, according to the CDC.

Abbott, one of the largest formula-makers in the U.S., has reached an agreement with the government to bring a closed factory back on line. And the FDA is easing some restrictions on imported formula.

Sturgis plant will reopen soon as nationwide out-of-stock levels of baby formula rise above 40%.

President Joe Biden's administration has announced new steps to ease the national shortage of baby formula, including allowing more imports from overseas.

States have been asked to increase accessibility of baby formula for recipients of the low-income program. And the Food and Drug Administration is looking at ways to make it easier to import formula.

The Food and Drug Administration has set tentative dates in June to publicly review COVID-19 vaccines for the youngest American children.

The U.S. government has released its long-awaited plan to ban menthol cigarettes and flavored cigars.

Vacant high-ranking positions across the executive branch could be taking a toll on the Biden administration.

The Senate voted on Tuesday to confirm Dr. Robert Califf to head the agency on a 50-46 vote. The agency has been without a permanent leader for the last 13 months.

Califf already served as FDA commissioner under the Obama administration.

Robert Califf testifies during the Senate Health, Education, Labor and Pensions Committee hearing on the nomination to be commissioner of the Food and Drug Administration on Tuesday, Dec. 14, 2021. The Senate narrowly confirmed Dr. Robert Califf as Food and Drug Administration commissioner on Tuesday, over objections to his pharmaceutical industry ties and concerns he would not act aggressively enough to stem the opioid epidemic. "Dr. Califf is a supremely qualified nominee with bipartisan support," said Sen. Richard Burr, the ranking Republican on the Senate health committee, before Tuesday's vote. Califf is a prominent cardiologist with extensive clinical research experience who served as FDA commissioner during President Barack Obama's final year in office. Biden has said Califf will bring a steady hand to the FDA as the drug regulator faces urgent decisions on Covid vaccines, therapeutics and testing to fight the pandemic.

The Senate has narrowly confirmed President Joe Biden’s pick to lead the Food and Drug Administration, filling a position that had been open for more than a year.

President Joe Biden’s pick to lead the powerful Food and Drug Administration has stalled in the narrowly divided Senate.

President Joe Biden’s pick to lead the Food and Drug Administration parried questions on crises ranging from the COVID pandemic to the opioid epidemic at his confirmation hearing Tuesday.

Califf also served in this role during the Obama administration.

Dr. Califf served as FDA commissioner for the last 11 months of President Barack Obama's second presidential term.

Dr. Califf served as FDA commissioner for the last 11 months of President Barack Obama's second presidential term.

Califf, a cardiologist, was briefly the agency's commissioner under the Obama administration beginning in 2016.

President Joe Biden is nominating former Food and Drug Administration Commissioner Dr. Robert Califf to again lead the powerful regulatory agency.

Califf served as FDA commissioner under former President Obama.

President Joe Biden is close to nominating former Food and Drug Administration Commissioner Dr. Robert Califf to lead the agency once again, the Washington Post reported Thursday. An Obama appointee, Califf helmed the FDA from February 2016 to February 2017 after a year as the agency's deputy commissioner for medical products and tobacco, according to the agency's website. His nomination would mark the end of a nine-month search for a permanent replacement for Acting Commissioner Dr. Janet Woodcock, who took over the agency on an interim basis in January. Biden must nominate Woodcock or choose another full-time commissioner by mid-November, the Post reported. A White House official told the Washington Post that Biden had not yet made his selection, while Califf declined to comment.

Full approval of Pfizer or Moderna's vaccines will embolden employers to mandate the shots and the companies to advertise on TV.